CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $218.8M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 3.52: safe zone
- Interpretations8 currently firing — 3 · 5
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
12.07%Above 5Y avg (9.03%)
Annual Rate
USD 1.25Paid quarterly
Payout Ratio
219.3%High
Paying Dividends
14 yr
Payback Period
8.7 yr
Last Ex-Dividend
Aug 19, 2026
Last Payment
Sep 9, 2026
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
Three-Year Dividend Growth With Elevated Dividends-to-FCF And Dividend-Stress Composite Firing
→common dividends to free cash flow
dividend growth rate standard
dividends exceed fcf
Elevated Yield With Deep Drawdown and Multi-Year FCF Shortfall
→dividend yield standard
dividends exceed fcf
drawdown from peak standard
High Dividend Payout With FCF And Equity Ratio
→dividend payout intensity
fcf positive 3y
ratio balance equity
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company return capital?
Diagnostic
Three-Year Dividend Growth With Elevated Dividends-to-FCF And Dividend-Stress Composite Firing
The dividend keeps rising — but for years it has cost more than the free cash flow that funds it.
Reads
Diagnostic
Elevated Yield With Deep Drawdown and Multi-Year FCF Shortfall
The yield looks high — but the price has fallen far, and free cash flow does not cover it.
Reads
High Dividend Payout With FCF And Equity Ratio
It pays out most of its earnings, on three years of positive free cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
218.80MUSDvs all stocks (USD)
Trailing P/E
18.35xvs Health Information Services peers
Revenue (TTM)
135.96MUSDvs all stocks (USD)
Profit Margin
9.00%vs Health Information Services peers
Beta
0.4210xvs all stocks
52-Week Change
-40.36%vs all stocks
Forward Annual Dividend Yield
12.07%vs all stocks
Market Capitalization
218.80MUSDvs all stocks (USD)
Enterprise Value
207.96MUSDvs all stocks (USD)
Trailing P/E
18.35xvs Health Information Services peers
Forward P/E
12.45xvs Health Information Services peers
PEG Ratio
-2.02xPrice to Sales (TTM)
1.61xvs Health Information Services peers
Price to Book (MRQ)
1.56xvs Health Information Services peers
Enterprise to Revenue
1.53xvs Health Information Services peers
Enterprise to EBITDA
9.43xvs Health Information Services peers
Gross Margin
80.47%vs Health Information Services peers
Profit Margin
9.00%vs Health Information Services peers
Operating Margin
19.91%vs Health Information Services peers
Return on Assets (TTM)
5.69%vs Health Information Services peers
Return on Equity (TTM)
8.42%vs Health Information Services peers
Revenue (TTM)
135.96MUSDvs all stocks (USD)
Revenue per Share (TTM)
6.56USDUpdated Sep 28, 2026Quarterly Revenue Growth
-1.90%vs Health Information Services peers
Gross Profit (TTM)
82.09MUSDvs all stocks (USD)
EBITDA (TTM)
24.37MUSDvs all stocks (USD)
Net Income (TTM)
12.24MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-9.50%vs Health Information Services peers
Operating Cash Flow (TTM)
28.58MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
20.81MUSDvs all stocks (USD)
Forward Annual Dividend Rate
1.25USDUpdated Sep 28, 2026Forward Annual Dividend Yield
12.07%vs all stocks
Trailing Annual Dividend Rate
1.25USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
12.07%vs all stocks
5-Year Average Dividend Yield
9.03%vs all stocks
Payout Ratio
219.30%vs Health Information Services peers
Revenue
139.71MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
29.79MUSDFY2025 · Dec 31, 2025Gross Profit
109.92MUSDFY2025 · Dec 31, 2025Operating Income
20.17MUSDvs all stocks (USD)
Pre-tax Income
21.44MUSDFY2025 · Dec 31, 2025Income Tax Expense
5.56MUSDFY2025 · Dec 31, 2025Net Income
15.88MUSDFY2025 · Dec 31, 2025EBIT
20.17MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
24.05MUSDFY2025 · Dec 31, 2025Research & Development
12.22MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
49.51MUSDFY2025 · Dec 31, 2025Other Operating Expenses
24.60MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
820.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
0.7700USDFY2025 · Dec 31, 2025EPS (Diluted)
0.7500USDFY2025 · Dec 31, 2025Basic Shares Outstanding
20.55MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
20.55MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
15.88MUSDFY2025 · Dec 31, 2025Operating Cash Flow
27.04MUSDFY2025 · Dec 31, 2025Free Cash Flow
23.29MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
25.28MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
15.88MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
3.34MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
5.17MUSDFY2025 · Dec 31, 2025Stock-based Compensation
5.01MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-734.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-1.96MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-1.74MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.08MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.75MUSDFY2025 · Dec 31, 2025Other Investing Activity
701.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.05MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-2.84MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-27.26MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-30.10MUSDFY2025 · Dec 31, 2025Shares Outstanding
20.91MSharesUpdated Sep 28, 2026Float Shares
18.21MSharesUpdated Sep 28, 2026Shares Short
679.66KSharesUpdated Sep 28, 2026Short Ratio
4.47daysvs all stocks
Short % of Shares Outstanding
3.50%vs all stocks
% Held by Insiders
2.26%vs all stocks
% Held by Institutions
57.97%vs all stocks
Total Cash (MRQ)
16.59MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.7930USDUpdated Sep 28, 2026Total Debt (MRQ)
5.75MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0411xvs Health Information Services peers
Current Ratio (MRQ)
1.09xvs Health Information Services peers
Book Value per Share (MRQ)
6.69USDUpdated Sep 28, 2026Total Assets
206.11MUSDvs all stocks (USD)
Total Current Assets
57.88MUSDFY2025 · Dec 31, 2025Total Liabilities
59.73MUSDFY2025 · Dec 31, 2025Total Non-current Assets
148.23MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
10.62MUSDFY2025 · Dec 31, 2025Total Current Liabilities
49.11MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
25.28MUSDFY2025 · Dec 31, 2025Accounts Receivable
22.64MUSDFY2025 · Dec 31, 2025Accounts Payable
3.98MUSDFY2025 · Dec 31, 2025Short-term Debt
2.68MUSDFY2025 · Dec 31, 2025Deferred Revenue
30.45MUSDFY2025 · Dec 31, 2025Other Current Liabilities
4.64MUSDFY2025 · Dec 31, 2025Long-term Debt
4.26MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
1.46MUSDFY2025 · Dec 31, 2025Common Stock (Book)
2.00KUSDFY2025 · Dec 31, 2025Retained Earnings
39.92MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
146.38MUSDvs all stocks (USD)
52-Week Low
9.95USDUpdated Sep 28, 202652-Week High
17.53USDUpdated Sep 28, 202652-Week Change
-40.36%vs all stocks
Beta
0.4210xvs all stocks
50-Day MA
10.73USDUpdated Sep 28, 2026200-Day MA
11.57USDUpdated Sep 28, 2026Avg 10-Day Volume
143.53KSharesUpdated Sep 28, 2026Avg 30-Day Volume
150.08KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
0.5700USDUpdated Sep 28, 2026Other Income / Expense
454.00KUSDFY2025 · Dec 31, 20255 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Goodwill-Heavy Equity
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
How is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 2.19Dividend per Share: 1.25Earnings per Share: 0.57
Financial Health
Altman Z-Score 3.52: safe zoneNotable
Altman Z-Score: 3.52
High earnings qualityNotable
Earnings Quality Score: 1.29
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $218.8M, lower than 95% of all stocks globallySignificant
Market cap (USD): 218,803,713Global P5: 275,556,405.438
Levered free cash flow is $20.81M, above the global median of $18.73MNotable
Levered free cash flow (USD): 20,814,624Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Kusurinomadoguchi Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Danal Co. Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Zaggle Prepaid Ocean Services Ltd.
Tier 1FlowRecurring-Revenue Lock-InRiskInterface
Beeks Financial Cloud Group PLC
Tier 1FlowRecurring-Revenue Lock-InProductionInterface
Fonix PLC
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Blend Labs Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Exodus Movement, Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceRisk
Hennge K.K.
Tier 1FlowRecurring-Revenue Lock-InRuleProduction
MTI Ltd.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
GMO Financial Gate Inc.
Tier 1FlowRecurring-Revenue Lock-InInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
PharmaEngine, Inc.
4 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Dividend Payout With FCF And Equity RatioFCF Ratios ElevatedDrawdown With FCF And Cash Backing
Zilltek Technology Corp.
3 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Dividend Payout With FCF And Equity RatioDrawdown With FCF And Cash Backing
Zhejiang Jianye Chemical Co., Ltd.
5 interpretationsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Dividend Payout With FCF And Equity RatioFCF Ratios ElevatedDrawdown With FCF And Cash BackingMulti-Year Debt Decrease With Cash Near Total Debt And Equity